278 related articles for article (PubMed ID: 15731567)
1. Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats.
Ikehara O; Nishimura H; Naito T; Higuchi C; Sanaka T
Nephron Exp Nephrol; 2005; 100(1):e30-9. PubMed ID: 15731567
[TBL] [Abstract][Full Text] [Related]
2. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
3. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
[TBL] [Abstract][Full Text] [Related]
4. Dissolved molecular hydrogen (H
Nakayama M; Zhu WJ; Watanabe K; Gibo A; Sherif AM; Kabayama S; Ito S
BMC Nephrol; 2017 Oct; 18(1):327. PubMed ID: 29089029
[TBL] [Abstract][Full Text] [Related]
5. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
6. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
7. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation.
Ha H; Yu MR; Choi HN; Cha MK; Kang HS; Kim MH; Lee HB
Perit Dial Int; 2000; 20 Suppl 5():S10-8. PubMed ID: 11229606
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
[TBL] [Abstract][Full Text] [Related]
9. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
10. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Biocompatible Peritoneal Dialysis Solutions.
Nataatmadja M; Cho Y; Johnson DW
Contrib Nephrol; 2017; 189():91-101. PubMed ID: 27951555
[TBL] [Abstract][Full Text] [Related]
12. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.
Kawanishi K; Honda K; Tsukada M; Oda H; Nitta K
Perit Dial Int; 2013; 33(3):242-51. PubMed ID: 23123670
[TBL] [Abstract][Full Text] [Related]
13. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.
Zheng ZH; Anderstam B; Qureshi AR; Heimbürger O; Wang T; Södersten P; Bergström J; Lindholm B
Kidney Int; 2002 Oct; 62(4):1447-53. PubMed ID: 12234318
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
[TBL] [Abstract][Full Text] [Related]
15. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products.
Wieczorowska-Tobis K; Brelinska R; Witowski J; Passlick-Deetjen J; Schaub TP; Schilling H; Breborowicz A
Perit Dial Int; 2004; 24(1):48-57. PubMed ID: 15104336
[TBL] [Abstract][Full Text] [Related]
16. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
17. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis.
Wang J; Zhu N; Yuan W
Nephron; 2015; 129(3):155-63. PubMed ID: 25765060
[TBL] [Abstract][Full Text] [Related]
18. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
19. "Biocompatible" Neutral pH Low-GDP Peritoneal Dialysis Solutions: Much Ado About Nothing?
Misra PS; Nessim SJ; Perl J
Semin Dial; 2017 Mar; 30(2):164-173. PubMed ID: 28251697
[TBL] [Abstract][Full Text] [Related]
20. Effect of balance Solution on the Peritoneal Membrane in Automated Peritoneal Dialysis.
De Los Ríos T; Pérez-Martínez J; Portoles J; Lichodziejewska-Niemierko M; Rivera M; Nowicki M; Książek A; Tato AM; Bohnhorst C; Feriani M
Perit Dial Int; 2016 9-10; 36(5):569-72. PubMed ID: 27659931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]